Das Klinikum
Dr. Yogesh Singh
Research Scientist/Project Leader
Medical Genetics and Applied Genomics
NGS Competence Centre Tübingen (NCCT)
Research Institute of Women's Hospital
Calwerstraße 7, 72076
Tübingen, Germany
Kontakt
Telefonnummer: 07071 29-78264
E-Mail-Adresse: yogesh.singh@med.uni-tuebingen.de
Klinik / Institut / Zentrum
Klinische Schwerpunkte
- Immunology (Cellular and Genomic Immunology)
- Microbiome and Inflammation
- Infection and Neurodegeneration
Wissenschaftliche Tätigkeit
- Innate and adaptive immune response after gut microbiome manipulation.
- Inflammatory signals in Parkinson's disease.
- Role of lipids in Parkinson's disease & detection of a-Syn using novel tools.
- Decipher the role of antigen-specific (TCR/BCR) immune response in COVID-19 using multi-OMICS methods.
Publikationen
- Singh Y, Trautwein C, Fendel R, Krickeberg N, Held J, Kreidenweiss A, Berezhnoy B, Bissinger R, Ossowski S, Salker MS, Casadei N, Riess O, the Deutsche COVID-19 OMICS Initiative (DeCOI). SARS-CoV-2 infection paralyzes cytotoxic and metabolic functions of immune cells. 2020. bioRxiv. https://doi.org/10.1101/2020.09.04.282780
- Singh Y, Trautwein C, Dhariwal A, Salker M, Alauddin M, Zizmare L, Pelzl L, Feger M, Admard J, Casadei N, Föller M, Pachauri V, Park D, Mak T, Frick J, Lang F, Riess O. DJ-1 (Park7) affects the gut microbiome, metabolites, and development of innate lymphoid cells. 2020. Scientific Reports
- Zhang S, al-Maghout T, Cao H, Pelzl L, Salker M, Veldhoen M, Cheng A, Lang F, Singh Y. Gut bacterial metabolit Urolithin A (UA) mitigates Ca2+ entry in T cells by regulating miRNA-10a-5p. Front. Immunology, 2019.
- Zur vollständigen Publikationsliste